Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

MLA

Thomas, Deborah A., et al. “Chemoimmunotherapy with Hyper‐CVAD plus Rituximab for the Treatment of Adult Burkitt and Burkitt‐type Lymphoma or Acute Lymphoblastic Leukemia.” Cancer, vol. 106, no. 7, Apr. 2006, pp. 1569–80. EBSCOhost, https://doi.org/10.1002/cncr.21776.

APA

Thomas, D. A., Faderl, S., O’Brien, S., Bueso, R. C., Cortes, J., Garcia, M. G., Giles, F. J., Verstovsek, S., Wierda, W. G., Pierce, S. A., Shan, J., Brandt, M., Hagemeister, F. B., Keating, M. J., Cabanillas, F., & Kantarjian, H. (2006). Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia. Cancer, 106(7), 1569–1580. https://doi.org/10.1002/cncr.21776

Chicago

Thomas, Deborah A., Stefan Faderl, Susan O’Brien, Ramos, Carlos Bueso, Jorge Cortes, Manero, Guillermo Garcia, Francis J. Giles, et al. 2006. “Chemoimmunotherapy with Hyper‐CVAD plus Rituximab for the Treatment of Adult Burkitt and Burkitt‐type Lymphoma or Acute Lymphoblastic Leukemia.” Cancer 106 (7): 1569–80. doi:10.1002/cncr.21776.